35 computer-programmer-"Multiple"-"U"-"O.P"-"U.S" "Prof" positions at University of Tübingen
Sort by
Refine Your Search
-
21.07.2025 Application deadline: 05.08.2025 The chair for Applied Bioinformatics at the University of Tübingen, Germany (Prof. Oliver Kohlbacher) is looking for a Postdoctoral Researcher position in
-
, the collective organisation of our outreach programme and other academic events. Applicants must have adequate language skills in academic English to actively participate in the research and qualification
-
” (funded by the German Research Foundation, DFG). PhD Researcher in Computational Linguistics (m/f/d, E13 TV-L, 75%) The position begins on 01 October 2025 and ends on 30 June 2029. The position is
-
04.06.2025 Application deadline: 01.07.2025 The chair in Law and Artificial Intelligence at the Faculty of Law at the University of Tübingen, held by Prof. Dr. Michèle Finck currently has one
-
for Theoretical Physics at the University Tübingen, Germany, in the group of Prof. Daniel Braun. Depending on a DFG funding decision, an upgrade to 75% of an E13 TV-L position might be possible after the first year
-
the German Research Foundation (DFG), at the University of Tübingen. The project is led by Principal Investigators Prof. Dr. Michael Franke, Dr. Marlen Fröhlich (both Tübingen) and Prof. Dr. Manuel Bohn
-
of Tübingen. The project is led by Principal Investigators Dr. Marlen Fröhlich, Prof. Dr. Michael Franke (both Tübingen) and Prof. Dr. Manuel Bohn (Lüneburg). The successful candidate will support the project
-
) in stellar astrophysics. The successful candidate will work on the Accretion process in Young Stellar Objects. The focus is on targets from the Hubble Space Telescope ULLYSES program for which optical
-
international researchers who would like to continue a promising research program in a highly stimulating research context that values ideas, innovation, and independent thinking. We offer the perfect
-
Building. You will join the Research Unit for Molecular Pharmacology, led by Prof. Timo Müller. The group's research is dedicated to the development of innovative pharmacotherapies aimed at safely and